HistologiX

HistologiX is a contract research organisation specialising in tissue-based analysis for preclinical and clinical research. With a GLP- and GCP-compliant laboratory in Nottingham, England, the company partners with scientists to support projects from discovery through to clinical development. Its services include histology, cellular pathology, immunohistochemistry (IHC), immunofluorescence (IF), in situ hybridisation (ISH), and digital pathology and image analysis.

HistologiX helps clients investigate biomarkers, analyse cell and tissue samples, and characterise therapeutic antibodies. Its work supports development programmes involving cell therapies, novel antibody classes, oncolytic viruses, immuno-oncology therapeutics, and RNA-modifying enzymes. Additional capabilities include tissue cross-reactivity, clinical trials, and histology supporting toxicology studies.

The company provides bespoke project design, assay development, sample handling, and data analysis, adapting protocols to each project and its materials. Teams may include a Study Director, scientists, and a dedicated client account contact. HistologiX can also advise on antibodies, control tissues, and appropriate study approaches, or work with materials supplied by clients. It is part of The Niche CRO Group.